Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis

by Guarnera C, Bramanti P, Mazzon E
Published 2017-07-01

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis

by Guarnera C, Bramanti P, Mazzon E
Published 2017-07-01

Moringin activates Wnt canonical pathway by inhibiting GSK3β in a mouse model of experimental autoimmune encephalomyelitis

by Giacoppo S, Soundara Rajan T, De Nicola GR, Iori R, Bramanti P, Mazzon E
Published 2016-10-01

A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients

by Gugliandolo A, Longo F, Marrosu MG, Mancardi GL, Gandoglia I, Melis M, Lo Giudice F, Bramanti P, Mazzon E
Published 2018-09-01

A novel role in skeletal segment regeneration of extracellular vesicles released from periodontal-ligament stem cells

by Diomede F, D'Aurora M, Gugliandolo A, Merciaro I, Ettorre V, Bramanti A, Piattelli A, Gatta V, Mazzon E, Fontana A, Trubiani O
Published 2018-06-01